Shanghai Fosun Pharmaceutical Group Co Ltd (600196): Eigentümerstruktur
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 21,6 Renminbi Yuan | 32,45 Renminbi Yuan | 20,85 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 33,5 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 2.118.488.825 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Shanghai Fosun Pharmaceutical Group Co Ltd
Mitarbeiter 40.684
Handelsplatz SHG
Ticker Symbol 600196
IPO Datum 1998-06-25
Adresse Building A, Shanghai, China, 200233
Webseite https://www.fosunpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Xiaohui Guan | Executive Co-Chairman |
| 2 | Mr. Yuqing Chen | Executive Chairman |
| 3 | Dr. Yi Liu | CEO, Chair of Fosun MedTech, Co-Chair of Innovative Medicines Division & Exec Director |
| 4 | Mr. Deyong Wen | Executive Vice Chairman |
| 5 | Ms. Rongli Feng | Executive President & Chief Human Resources Officer |
| 6 | Ms. Jing Li | Co-President and CEO of Mature Products and Manufacturing Business Unit |
| 7 | Mr. Wang Xingli M.D., Ph.D. | Co-President & CEO of the Innovative Drugs Business Unit |
| 8 | Mr. Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division |
| 9 | Mr. Xiang Li DPHIL | SVP, Co-President & CSO of the Innovative Drugs Business Unit |
| 10 | Ms. Jia Yan | Chief Accountant, Co-CFO & Assistant to the President and Employee Director |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.